About
UVFTRIO
UVFTRIO cap is a prescription medication marketed by Innoglide Pharmaceutical pvt. Ltd., primarily used for the maintenance treatment of Chronic Obstructive Pulmonary Disease (COPD) and uncontrolled asthma. It combines three active ingredients: Fluticasone Furoate (100 mcg), Umeclidinium (62.5 mcg), and Vilanterol (25 mcg).
UVFTRIO is available by prescription only and should be used as directed by a healthcare professional.
Consult your healthcare provider for proper guidance on the use of UVFTRIO.
